Healthcare provider profile · identity verified

Shawn Michael Baxter, D.O.

Family Practice · SPOKANE VALLEY, WA · NPI 1174884688

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	653	187
Levothyroxine Sodium	Levothyroxine Sodium	644	159
Atorvastatin Calcium	Atorvastatin Calcium	579	165
Losartan Potassium	Losartan Potassium	461	137
Omeprazole	Omeprazole	440	127
Amlodipine Besylate	Amlodipine Besylate	342	111
Trazodone Hcl	Trazodone Hcl	301	80
Metformin Hcl	Metformin Hcl	290	80
Simvastatin	Simvastatin	288	85
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	287	87
Furosemide	Furosemide	251	79
Potassium Chloride	Potassium Chloride	233	69
Sertraline Hcl	Sertraline Hcl	225	64
Metoprolol Succinate	Metoprolol Succinate	224	76
Gabapentin	Gabapentin	217	69
Pantoprazole Sodium	Pantoprazole Sodium	200	54
Tamsulosin Hcl	Tamsulosin Hcl	185	60
Rosuvastatin Calcium	Rosuvastatin Calcium	182	57
Montelukast Sodium	Montelukast Sodium	175	51
Albuterol Sulfate Hfa	Albuterol Sulfate	168	74
Allopurinol	Allopurinol	142	38
Hydrochlorothiazide	Hydrochlorothiazide	136	46
Lovastatin	Lovastatin	126	35
Escitalopram Oxalate	Escitalopram Oxalate	122	36
Eliquis	Apixaban	118	36
Bupropion Xl	Bupropion Hcl	116	33
Metformin Hcl Er	Metformin Hcl	116	35
Citalopram Hbr	Citalopram Hydrobromide	113	33
Pravastatin Sodium	Pravastatin Sodium	109	28
Tramadol Hcl	Tramadol Hcl	109	40
Metoprolol Tartrate	Metoprolol Tartrate	106	29
Prednisone	Prednisone	103	71
Carvedilol	Carvedilol	100	26
Glipizide Er	Glipizide	98	24
Spironolactone	Spironolactone	93	29
Clopidogrel	Clopidogrel Bisulfate	87	28
Fluoxetine Hcl	Fluoxetine Hcl	81	21
Fluticasone Propionate	Fluticasone Propionate	81	32
Duloxetine Hcl	Duloxetine Hcl	80	21
Alendronate Sodium	Alendronate Sodium	74	21
Tizanidine Hcl	Tizanidine Hcl	70	35
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	69	19
Hydroxyzine Hcl	Hydroxyzine Hcl	69	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	69	18
Famotidine	Famotidine	68	21
Amitriptyline Hcl	Amitriptyline Hcl	67	21
Pioglitazone Hcl	Pioglitazone Hcl	67	16
Cephalexin	Cephalexin	66	19
Zolpidem Tartrate	Zolpidem Tartrate	60	22
Alprazolam	Alprazolam	56	17
Donepezil Hcl	Donepezil Hcl	56	18
Ropinirole Hcl	Ropinirole Hcl	56	16
Jardiance	Empagliflozin	55	14
Olanzapine	Olanzapine	49	suppressed
Buspirone Hcl	Buspirone Hcl	48	15
Oxycodone Hcl	Oxycodone Hcl	48	12
Synthroid	Levothyroxine Sodium	48	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	48	16
Lorazepam	Lorazepam	47	28
Oxybutynin Chloride Er	Oxybutynin Chloride	46	18
Propranolol Hcl	Propranolol Hcl	46	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	46	31
Ozempic	Semaglutide	44	13
Ventolin Hfa	Albuterol Sulfate	44	15
Nystatin	Nystatin	43	21
Pregabalin	Pregabalin	43	13
Januvia	Sitagliptin Phosphate	42	14
Atenolol	Atenolol	39	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	39	14
Sumatriptan Succinate	Sumatriptan Succinate	39	suppressed
Xarelto	Rivaroxaban	39	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	38	suppressed
Finasteride	Finasteride	37	11
Meloxicam	Meloxicam	37	17
Memantine Hcl	Memantine Hcl	37	11
Ezetimibe	Ezetimibe	35	suppressed
Estradiol	Estradiol	34	12
Oxybutynin Chloride	Oxybutynin Chloride	34	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	31	suppressed
Acyclovir	Acyclovir	30	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	30	15
Methocarbamol	Methocarbamol	30	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	29	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	suppressed
Baclofen	Baclofen	26	suppressed
Clobetasol Propionate	Clobetasol Propionate	26	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	26	23
Fenofibrate	Fenofibrate Nanocrystallized	26	suppressed
Fluconazole	Fluconazole	26	16
Diclofenac Sodium	Diclofenac Sodium	25	suppressed
Valacyclovir	Valacyclovir Hcl	25	14
Lamotrigine	Lamotrigine	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	23	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Ciclopirox	Ciclopirox Olamine	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Ipratropium Bromide	Ipratropium Bromide	22	12
Morphine Sulfate Er	Morphine Sulfate	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	suppressed
Ondansetron Odt	Ondansetron	22	13
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Torsemide	Torsemide	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	20
Humulin R U-500 Kwikpen	Insulin Regular, Human	21	suppressed
Ketoconazole	Ketoconazole	21	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Prazosin Hcl	Prazosin Hcl	19	suppressed
Solifenacin Succinate	Solifenacin Succinate	19	suppressed
Lactulose	Lactulose	18	suppressed
Methylphenidate Er	Methylphenidate Hcl	18	suppressed
Colchicine	Colchicine	17	suppressed
Glipizide	Glipizide	17	suppressed
Metronidazole	Metronidazole	17	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Topiramate	Topiramate	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	16	suppressed
Clonazepam	Clonazepam	16	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Klor-Con 10	Potassium Chloride	16	suppressed
Levemir Flexpen	Insulin Detemir	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Lidocaine	Lidocaine	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Risperidone	Risperidone	15	suppressed
Cefdinir	Cefdinir	14	13
Chlorthalidone	Chlorthalidone	14	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Naproxen	Naproxen	14	suppressed
Nyamyc	Nystatin	14	suppressed
Calcitriol	Calcitriol	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Azithromycin	Azithromycin	12	12
Cefuroxime	Cefuroxime Axetil	12	12
Clonidine Hcl	Clonidine Hcl	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Febuxostat	Febuxostat	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Olanzapine Odt	Olanzapine	12	suppressed
Potassium Citrate Er	Potassium Citrate	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Diazepam	Diazepam	11	suppressed
Digoxin	Digoxin	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Phenobarbital	Phenobarbital	11	suppressed
Ramipril	Ramipril	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error